Showing posts with label Invasive. Show all posts
Showing posts with label Invasive. Show all posts

Tuesday, 2 May 2017

Minimally Invasive Surgery Market In Latin America (Surgical Devices, Monitoring & Visualization Devices and Endoscopy Devices) During The Period 2014 - 2020

ResearchMoz presents this most up-to-date research on "Minimally Invasive Surgery Market In Latin America (Surgical Devices, Monitoring & Visualization Devices and Endoscopy Devices) During The Period 2014 - 2020".

Minimally invasive surgeries (MISs) are type of surgeries that are performed using technologically advanced devices and instruments, with smaller incisions on the patient’s body. The goal for minimally invasive surgery is to reduce the risk of infection and promote rapid healing. This report studies the market for minimally invasive surgery in Latin America from three perspectives. They are, namely, the types of devices used in performing these surgeries, various types of surgeries performed in the markets of Latin America and major geographic markets of Latin America. The devices segment has been further partitioned into three main categories: surgical devices, monitoring and visualization devices and endoscopy devices. Surgical devices are further classified as ablation devices, electrosurgical devices and medical robotic systems. Similarly, the monitoring and visualization devices segment has also been divided into MRI equipment, CT scanners, X-ray devices, ultrasound equipment and other (PET and SPECT scanners and combination devices such as PET/CT, PET/MRI, SPECT/CT and SPECT/MRI).

The various types of minimally invasive surgeries performed have also been provided in the report. The market for minimally invasive surgery in Latin America has been segmented into orthopedic (spinal and joint replacement), cosmetic, breast, vascular, thoracic, gynecological, bariatric, cardiac, gastrointestinal and urological surgeries. Geographically, the market in Latin America comprises six segments: Brazil, Mexico, Colombia, Argentina, Chile and Others. This report provides market size and forecast for each device type and surgery type, along with their sub segments (if any) for the period from 2012 to 2020, in terms of revenue (USD million), considering 2012 and 2013 as the base years. The report also provides the compounded annual growth rate (CAGR %) during the forecast period from 2014 to 2020 for all the aforementioned segments and sub segments.

The market overview section of the report discusses the market dynamics with respect to market drivers, restraints and opportunities. This section also covers Porter’s five forces analysis for the market for minimally invasive surgery in Latin America. Moreover, the regulatory scenario (clinical trends) and event impact analysis have been provided in this section. The event impact analysis comprises the study of various events that have occurred in the past 5 to 10 years and of events that are expected to occur during the forecast period. The impact (positive or negative) of these events has also been discussed in this analysis. Heat map analysis of the leading market players for the year 2013 has been provided in this section. It is followed by a list of recommendations for existing players to enter and enhance their market shares and for new players to enter the market, respectively. The report concludes with the company profiles of key players operating in various segments of the market. Each company profile includes the company overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the minimally invasive surgery market that have been profiled in this report include Intuitive Surgical, Inc., GE Healthcare, Philips Healthcare, Siemens Healthcare, Medtronic, Inc., Stryker Corporation, Biomet, Inc. and DePuy Synthes, Inc.


The Latin America minimally invasive surgery market has been segmented as below:

Latin America Minimally Invasive Surgery Market, by Product Types
  • Surgical Devices
  • Ablation Devices
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Others
  • Electrosurgical Devices
  • Medical Robotic Systems
  • Monitoring & Visualization Devices
  • X-Ray Devices
  • Computed Tomography (CT) Scanners
  • Magnetic Resonance Imaging (MRI) Equipment
  • UltrasoundEquipment
  • Others
  • Endoscopy Devices
Latin America Minimally Invasive Surgery Market, by Type of Surgery
  • Orthopedic Surgery
  • Spinal Surgery
  • Joint Replacement Surgery
  • Cosmetic Surgery
  • Breast Surgery
  • Vascular Surgery
  • Thoracic Surgery
  • Gynecological Surgery
  • Bariatric Surgery
  • Cardiac Surgery
  • Gastrointestinal Surgery
  • Urological Surgery
Latin America Minimally Invasive Surgery Market, by Country
  • Brazil
  • Mexico
  • Colombia
  • Chile
  • Argentina
  • Others

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=237585

Wednesday, 22 February 2017

2017 - 2020: Antifungal Global Market With Focus on Invasive Fungal Infections

Researchmoz added Most up-to-date research on "2017 - 2020: Antifungal Global Market With Focus on Invasive Fungal Infections" to its huge collection of research reports.

The report titled Global Antifungal Market With Focus on Invasive Fungal Infections: 2016-2020 provides an in-depth analysis of the global antifungal market with detailed analysis of market size on the basis of value along with the comprehensive examination of each of the segments of the market, namely, Azole, Echinocandins and Polyene.

The report analysis the invasive fungal infection market extensively with the market size, in terms of value along with the market segments and the major products in the market. This section also provides information about the regional market share of the global invasive fungal infection market. The report provides detailed regional analysis of the United States, Europe and Latin America. The regional analysis of the antifungal market includes market size by value along with the geographic overview of the market in the concerned region.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global antifungal market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global antifungal market is stiff and dominated by the big players like Pfizer. Further, key players of the market, Merck and Scynexis are also profiled with their financial information and respective business strategies.

Regional Coverage
United States
Europe
Latin America

Company Coverage
Pfizer, Inc.
Merck Co., Inc.
Scynexis, Inc.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=841066

Executive Summary
The global antifungal market witnessed an upsurge at a significant CAGR during 2012-2015 and projections are made that the market would rise in the next five years i.e. 2016-2020 tremendously. The market is spread across the globe with the United States and Europe dominating the market, while Asia-Pacific and Latin America market are the fastest growing markets.

The antifungal market can be segmented on the basis of types of drugs into Polyene, Azole and Echinocandins. The Azole class of antifungals dominates the market followed, by Echinocandins and Polyene. Azoles are broadly categorized as Voricanazole, Imidazole, Triazole and Thiazoles. Of which, Voricanazole govern the market. Echinocandins antifungal class is subjugated by Caspofungin, while other antifungals include Micafungin, and Anidulafungin. The Polyene antifungal agents include Amphotericin B, Nystatin, and Natamycin. Though, Amphotericin B is the only widely used agent in the market.

The fungal infections do not usually result in severe ailment, but in people with weak immune system, minor fungal infections can move in the bloodstreams and conquer critical organs leading to the damage, called as invasive fungal infection. The global market for the invasive fungal infection increased significantly during 2010-2015 and is expected to upsurge further.

The major growth drivers for the global antifungal market are: the rise in the incidences of fungal infection, aging population and unhygienic conditions all over the world. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as: antifungal resistance, traditional treatments for fungal infection, side-effects of antifungal medication and antifungal development failures Some of the recent trends in the market include technological advancement, growth in resistant strains and generic competition.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=841066